Pierre Fabre Adopts ³Ô¹Ï±¬ÁÏ OpenData to Enhance Commercial Execution
³Ô¹Ï±¬ÁÏ OpenData will provide field teams across 22 countries
with accurate customer reference data for better HCP engagement
PLEASANTON, CA ¡ª Nov. 29, 2018 ¡ª ³Ô¹Ï±¬ÁÏ Systems (NYSE:VEEV) today announced global pharmaceutical and dermo-cosmetics company adopted ³Ô¹Ï±¬ÁÏ OpenData for accurate customer data to strengthen healthcare professional (HCP) engagement for its dermo-cosmetics business. Building on its success with ³Ô¹Ï±¬ÁÏ CRM, the company will now have reliable, complete customer data to help medical representatives deliver greater value in HCP interactions.
¡°We wanted to give our medical reps around the world access to high quality customer data,¡± said Vincent Lacour, program manager at Pierre Fabre. ¡°³Ô¹Ï±¬ÁÏ OpenData will enable them to target customers more effectively and deliver the right message at the right time.¡±
With hundreds of reps in 22 countries across Europe, North America, South America, and Australia, Pierre Fabre wanted to standardize on one global solution for customer data. ³Ô¹Ï±¬ÁÏ OpenData gives teams easy access to an accurate view of their customers to drive smarter, informed interactions. To maintain productivity, reps can submit data change requests (DCRs) directly to ³Ô¹Ï±¬ÁÏ¡¯s global team of expert data stewards that validate and update DCRs within hours.
¡°³Ô¹Ï±¬ÁÏ responds to change requests and verifies updates to customer data quickly,¡± added Vincent Lacour, program manager at Pierre Fabre. ¡°³Ô¹Ï±¬ÁÏ OpenData ensures our reps are working with accurate information to stay productive, compliant, and focused on the customer.¡±
Organizations from emerging biotechs to the largest pharmaceutical companies are using ³Ô¹Ï±¬ÁÏ OpenData, which provides access to approximately 16 million HCPs and their healthcare organizations spanning 42 countries. Leading companies, including 16 of the top 20 pharmaceutical companies, have?made the switch to ³Ô¹Ï±¬ÁÏ OpenData?in various regions to increase field effectiveness and enhance customer engagement.
¡°Pierre Fabre is implementing an innovative global strategy to strengthen customer relationships for its dermo-cosmetics business,¡± said Guillaume Roussel, director of strategy, ³Ô¹Ï±¬ÁÏ OpenData, Europe. ¡°³Ô¹Ï±¬ÁÏ OpenData will give the company real-time access to accurate customer information to improve commercial execution.¡±
Additional Information
For more on ³Ô¹Ï±¬ÁÏ OpenData, visit: veeva.com/³Ô¹Ï±¬ÁÏOpenData
Connect with ³Ô¹Ï±¬ÁÏ on LinkedIn:
Follow @veevasystems on Twitter:
Like ³Ô¹Ï±¬ÁÏ on Facebook:
About ³Ô¹Ï±¬ÁÏ Systems
³Ô¹Ï±¬ÁÏ Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ has more than 675 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. ³Ô¹Ï±¬ÁÏ is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. For more information, visit veeva.com.
Forward-looking Statements
This release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ¡¯s products and services, the results from use of ³Ô¹Ï±¬ÁÏ¡¯s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ¡¯s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ¡¯s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ¡¯s financial results are included under the captions, ¡°Risk Factors¡± and ¡°Management¡¯s Discussion and Analysis of Financial Condition and Results of Operations,¡± in the company¡¯s filing on Form 10-Q for the period ended July 31, 2018. This is available on the company¡¯s website at veeva.com under the Investors section and on the SEC¡¯s website at . Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.
###
Contact:
³Ô¹Ï±¬ÁÏ Systems
pr@veeva.com
Jeremy Whittaker
³Ô¹Ï±¬ÁÏ Systems
+49 6950955486
jeremy.whittaker@veeva.com